Sema4 Purchases GeneDx Platform
GeneDx providers expertise in rare disease diagnostic and exome sequencing services.
Stay updated with breaking news from Eric Schadt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
GeneDx providers expertise in rare disease diagnostic and exome sequencing services.
Sema4 (Nasdaq: SMFR) acquires GeneDx, a leader in genomic testing and analysis, at a purchase price representing approximately $623 million.
In its largest-ever deal, Stamford-based Sema4 has agreed to a $623 million acquisition...
Sema4 Announces Preliminary Revenue for the Fourth Quarter and Fiscal Year 2021 Fourth quarter and fiscal year results are expected to exceed the high end of... | January 10, 2022
Code Ocean Announces $21 Million in Funding to Accelerate in Biotech Share Article Code Ocean has raised $21 million to accclerate development of its leading computational research environment “Code Ocean is riding the next wave of innovative companies who are reinventing scientific tools and platforms," said Scott Tobin, General Partner, Battery Ventures NEW YORK (PRWEB) May 17, 2021 Code Ocean, the leading computational research environment for sharing scientific discoveries, today announced that it has raised a total of $21 ...